Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo

Ann Rheum Dis. 2007 Jan;66(1):138-40. doi: 10.1136/ard.2006.055541.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / pathology
  • Female
  • Health Status Indicators*
  • Humans
  • Infliximab
  • Joints / pathology
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab